Shenzhen Main Luck Pharmaceuticals Inc - Company Review
Shenzhen Main Luck Pharmaceuticals Inc - Company ReviewSummary
Shenzhen Main Luck Pharmaceuticals Inc (Main Luck Pharma) is a healthcare products provider that manufactures and markets anti-tumour medicines. The company's products include 10-hydroxycamptothecin, paclitaxel, docetaxel, vinorelbine, ifosfamide, mesna, pirarubicin, aclarubicin, adriamycin, daunorubicin, vincristine, bleomycin, and lastet. Its products are used in the treatment of carcinoma of testis, ovarian and breast cancer, soft tissue sarcoma, malignant lymphoma, and lung cancer. Main Luck Pharma imports equipments and instruments from the US, the Netherland, Japan, Switzerland,and Germany. The company markets its products in Pakistan, Russia, and across China. Main Luck Pharma is headquartered in Shenzhen, China.
This comprehensive company report of Shenzhen Main Luck Pharmaceuticals Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.